Introduction
Hepatitis B virus (HBV) infection is a major cause of mortality and morbidity globally. Hepatitis B is a major cause of chronic liver disease and a significant public health issue. Progress in understanding of the natural history of hepatitis B made it possible the mathematical formulation of its dynamics in populations and the construction of epidemiologic models. The quest continues to identify viral factors that influences disease progression and severity as well as responses to treatment of HBV infection. Hepatitis B virus, abbreviated HBV, is a species of the genus Orthohepadnavirus, which is likewise a part of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B. Approximately 5% of the worlds population is infected with hepatitis B virus(HBV). There are approximately 400 million HBV carriers worldwide, of whom 75%-80% reside in Asia and the Western Pacific. Chronic hepatitis B(CHB) is responsible for 1 million deaths per year globally (Tibbs and Simth (2001) ). Hepatitis is common disease world wide, specially, in Bangladesh. As a country of the Asia Pacific region Bangladesh is considered to be a high risk country for developing hepatitis A and B (Parvin et al (2011) ). In particular, HBV lead to chronic disease in hundreds of millions of people and the most common cause of liver cirrhosis and cancer (WHO, 2011). As a south East Asian country Bangladesh is considered endemic for hepatitis B virus (HBV) infection (Chowdhury et al (2009) ). Bangladesh is a densely populated country where about 10 million people are chronically infected with hepatitis B virus (HBV) (Ahmad et al (2008) ). Bangladesh is a densely populated country with about 150 million people, where HBsAg positivity in the healthy adult population is 7.2%-7.5% (Islam et al (1984) , Khan and Ahmad (1996) ). In Bangladesh, most HBV infections occur in childhood as suggested by the high rate of interfamilial HBV infection, history of low rate of acute hepatitis and large number of younger populations affected.
Hepatitis has become an issue of global importance, and in Bangladesh, hepatitis B virus infections still remain a public health problem. Those who have the infection may develop chronic hepatitis eventually leading to cirrhosis and hepatocellular carcinoma. In a study conducted by the World Health Organization, an estimated 2 billion people have been infected with hepatitis B at some time in their life worldwide(WHO(1998)).The prevalence of hepatitis B infection varies in different regions. In Bangladesh, the prevalence of HBsAg(+) reported a value of 8% in IV drug users and a value of 9.7% in commercial sex workers and 5.9% in truck drivers (Gibney et al (2001) ). Chronic infection developed in 90% of neonates infected with hepatitis B; in 20% -50% of children below the age of 10 but in only 2% to 7% of adults (Hsu Hy et al (1992) ) .The infection with Hepatitis B virus (HBV) is a major health problem in the world. The WHO has reported that more than 2 billion people worldwide has been infected by HBV. There are over 350 millions who are chronically infected with HBV. Mathematical analysis of the HBV dynamics not only provide important quantitative insights into the pathogenesis, but also lead to design treatment strategies which would more effectively bring the infection under control. Hepatitis B dynamics from the point of view of quantitative epidemiology is far from being simple and straightforward matter due to the chronicity of infection. Using modeling techniques and the new knowledge on biology and epidemiology, the efforts have been made to construct such models and to use then in solving II.
Formulation of Model
We design a mathematical model to understand the transmission dynamics and prevalence of HBV. The model is constructed based on the characteristics of HBV transmission and the model of Medley(2001) . Note that, there is considered only five epidemiological groups and those did not distinguish the recovery and vaccinated subgroups (Zou et al (2010) ). In our model, the latent, carrier and recovered individuals may be reinfected at any time by the contact of HBV infected individuals. Some studies (Mandell et al (1979) , Shepard et al (2006) ) indicated that acute hepatitis B could be found today in newborns of infected mothers. The total homogeneously-mixing population at time t, is denoted by N(t). The total host population is sub-divided into six epidemiological groups: the susceptible individuals (X(t)), individuals who are protective immunized by vaccination (Y(t)), infected but not yet infectious (latent) (L(t)), acute infected individuals (I(t)), chronic HBV carriers (C(t)) and acquiring treatment recovered individuals (R(t)) but can get infection at any time by contact of HBV infected individuals, so that
N(t) = X(t) + Y (t) + L(t) + I(t) + C(t) + R(t).
The susceptible population is decreased by infection, which can be acquired following effective contact with infectious individuals in acute (I) and chronic carriers(C), at a rate λ given by
In (1); β represents the effective contact rate (i.e. contact capable of leading to HBV infection);η is the modification parameter; the infectiousness of carriers relative to acute infections. We assume that 0 < η < 1.
The susceptible individuals consists of un protective immunized population with portion of infected carrier mothers μω(1-νC), that means newborns are un immunized and become susceptible individuals and decreased by vaccination ( at a rate σ ) and natural death ( at a rate μ 1 ) and increased by unsuccessful vaccination ( at a rate (1-σ)). Thus the rate of change of the susceptible population is given by
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The protective immunized individual is increased by the recruitment of newborns successfully immunized at rate μ(1-ω) and vaccinated susceptible individuals and decreased by unsuccessful vaccination ( at a rate (1-σ)) and natural death ( at a rateμ 1 ). Thus the rate of change of protective immunized population is given by
ν is the portion of unimmunized children born to carrier mothers that have been infected, which means that babies have infected in perinatal infection and access to latent class. A fraction ξ , of the newly infected individuals are assumed to show no disease symptoms initially. These individuals (known as slow progressors) are moved to latent class (L). The remaining fraction, 1-ξ , of the newly infected individuals are assumed to immediately display disease symptoms(fast progressors) and are moved to the acute class (I). The population of latent individuals is decreased by the progression of latent individuals to acute HBV ( at a rate ε 1 ) and at ω 1 fraction of latent individuals who develop symptoms and are detected. These individuals is also reduced by the transmission probability, β 1 with transfer rate ε 2 from latent to carrier class and re-infection ( at a rate ω 2 ψ e λ , where ψ e < 1 accounts for the assumption that latent individuals have reduced infection rate in comparison to susceptible individuals and ω 2 is the fraction of re-infected latent individuals who are detected. It is further reduced by natural death (at a rateμ 1 ). Thus
The population of acute HBV individuals is increased by the infection of fast progressors(at the rate (1 − ξ)λ and the development of symptoms by latent individuals (at the rate ω 1 ε 1 ). It is further increased by the reinfection of latent individuals ( at the rate ω 2 ψ e λ ) and re-infection of carrier individuals ( at the rate ω 3 ψ c λ), where ω 3 is the fraction of re-infected carriers individuals who are detected. The acute HBV individuals is decreased by the transmission probability, β 2 with the transfer rate ε 3 from acute to carrier class and acquiring treatment ( at the rate t 1 ), the individuals are transmitted with the probability, β 3 from acute to recover class. It is also reduced by disease induced death ( at the rate μ 2 ). Thus the governing equation is 
The population of chronic carrier individuals increases by the transfer rate, β 1 ε 2 from latent to carrier and the transfer rate, β 2 ε 3 from acute to carrier and re-infection of recovered individuals ( at the rate ω 4 ψ r λ ) where ω 4 is the fraction of re-infected recovered individuals who are detected. The population is decreased by re-infection of carrier individuals ( at the rate ω 3 ψ c λ) from carrier to acute HBV infected individuals and acquiring treatment ( at the rate t 1 ), with the transmission probability, β 4 from carrier to recovered individuals. It is also reduced by natural death ( at a rate μ 1 ) and disease induced death ( at the rate μ 2 ). Hence 
Recovery means recovery from illness acquiring treatment ( at the rate t 1 ) with transmission probability, β 3 and β 4 from acute to recovered and from carrier to recovered. But recovery rate is temporary and after some times these individuals can get re infection and go back to the carrier class ( at the rate ω 4 ψ r λ ) and decreased by natural death ( at a rate μ 1 ). Hence 
Based on the characteristics of HBV transmission the non-linear differential equations ( associated variables and parameters are described in Table 1) 
The important features of the model (8) are that it: (i) allows for disease transmission by individuals in the latent (L), acute (I) and carrier (C) classes;
(ii) latent individuals show their disease symptoms (at the rate ω 1 ) and move to the acute classes; (iii) allows for the re-infection of latent, carrier and recovered individuals (at the rates ψ e λ, ψ c λ and ψ r λ respectively); (iv) allows for slow progression (at the rate ξλ)to the latent class and fast progression (at the rate (1 − ξ)λ) to acute disease; (v) of re-infection individuals who develop symptoms (due to re-infection of disease) into the acute and carrier classes ; (vi) allows for the treatment (at a rate t 1 ), temporarily release from the disease into acute and carrier classes and moves to recovered class and can get re-infection at any time.
The model (8) extends the models in many of the aforementioned studies (Pang et al (2010) , Zhaoa et al (2010) ) by including treatment to the infected individuals. Furthermore it extends the study (Pang et al (2010)) using standard incidence and re-infection. Also, the model offers additional extensions to many of the earlier models by incorporating the slow and fast progression aspect of HBV disease (by splitting the number of new infected individuals into the latent (L) and acute(C) classes). The study further contributes to the literature by carrying out a detailed rigorous analysis of the model (8) . Here we consider the protective immunized new born carrier from chronic carrier to latent class (Pang et al (2010) ). Because some studies (Mandell et al (1979) , Shepard et al (2006) ) indicated that acute Hepatitis B could be found today in newborns of infected mothers. According to the change of the model (8), we analyze the dynamical behavior of our suggested model. proportion of birth rate with protective immunity σ vaccination rate (1 − σ) unsuccessful vaccination rate μ 1 natural mortality rate μ 2 mortality rate due to HBV λ force of infection β effective contact rate for HBV infection η rate of infectiousness of carrier relative to acute infections ε 1 transfer rate from latent to acute ε 2 transfer rate from latent to carrier ε 3 transfer rate from acute to carrier β 1 transmission probability from latent to carrier β 2 transmission probability from acute to carrier β 3 transmission probability from acute to recovered acquiring treatment β 4 transmission probability from carrier to recovered acquiring treatment t 1 rate of treatment (1 − ξ)
A fraction of the newly infected individuals who are fast progressors assumed to immediately display disease symptoms ψ e λ re infection rate, latent individuals have reduced infection rate in comparison to wholly susceptible individuals ω 1 fraction of latent individuals who develop symptoms are infected ω 2 fraction of re infected latent individuals who are infected ω 3 fraction of re infected carrier individuals who are infected ω 4 fraction of re infected recovered individuals who are infected 
III. Analysis of the Model
Disease Free Equilibrium(DFE): The model (8) has a DFE, obtained by setting the right-hand sides of the equations of the model to zero, given by
The stability of the DFE, ε 0 , will be analyzed using the next generation method (Driessche and Watmough (2002)). The non-negative matrix F (of the new infection terms) and the non-singular M-matrix V (of the remaining transfer terms) are given, respectively, by:
where, k 1 = ω 1 ε 1 + β 1 ε 2 + μ 1 , k 2 = β 2 ε 3 + β 3 t 1 + μ 2 and k 3 = β 4 t 1 + μ 1 + μ 2 and
The associated reproduction number, denoted by R 0 , is given by R 0 = ρ(FV -1 ), where ρ denotes the spectral radius (dominant eigenvalue in magnitude)-of the next generation matrix FV -1 . It follows that
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It can also be rewritten as (after some algebraic manipulation),
with, k 1 = ω 1 ε 1 + β 1 ε 2 + μ 1 , k 2 = β 2 ε 3 + β 3 t 1 + μ 2 , k 3 = β 4 t 1 + μ 1 + μ 2 , k 4 = β 1 k 2 + ω 1 β 2 . Hence, the result below follows from Theorem 2 of (Driessche and Watmough (2002)) .
Lemma 1. The Disease free equilibrium, ε 0 of the model (8) , is locally asymptotically stable (LAS) if R 0 < 1, and unstable if R 0 > 1.
The threshold quantity, R 0 , is the reproduction number for the model. The epidemiological implication of Lemma 1 is that HBV spread can be effectively controlled in the community (when R 0 < 1) if the initial sizes of the populations of the model are in the basin of attraction of the disease free equilibrium ε 0 .
Since we have considered HBV model with re-infection in some stages, are often shown the backward bifurcation, where the stable DFE co-exists with a stable endemic equilibrium when the associated reproduction threshold (R 0 ) is less than unity, it is instructive to determine whether or not the model (8) also exhibits this dynamical feature. This is investigated below. from which it can be shown (as before) that:
which is as defined in Section 3. Consider the case when R 0 = 1 . Suppose, further that β is chosen as a bifurcation parameter. Solving (11) 
Computations of a and b
For the partial derivatives in the equation for a in (12) gives : 
IV. Global Stability of the DFE of the Model
The result given in Lemma 2 (discounting the possibility of backward bifurcation when ψ e = ψ c = ψ r = 0) suggests that the DFE, ε 0 , of the model (8), may be globally asymptotically stable (GAS) when R 0 < 1 and ψ e = ψ c = ψ r = 0. This is explored below. 
V. Existence of Endemic Equilibrium Point (EEP):
Special Case In this section, the possible existence and stability of endemic (positive) equilibria of the model (8) (i.e., equilibria where at least one of the infected components of the model is non-zero) will be considered for the special case where exogenous re-infection does not occur (i.e., ψ e = ψ c = ψ r = 0). Let ε 1 = (X**, Y**,L**, I**,C**,R**) represents any arbitrary endemic equilibrium of the model (8) with ψ e = ψ c = ψ r = 0. Solving the equations of the system we have the following endemic equilibrium points (EEP) (8) with ψ e = ψ c = ψ r = 0 has a unique endemic equilibrium, given by ε 1 whenever R 0 > 1.
VI. Local Stability of EEP: Special Case
The local stability of the unique EEP, ε 1 , will now be explored for the special case where the diseaseinduced mortality is negligible (i.e., μ 2 = 0), no fast progression to active disease (i.e., ξ = 1) and re-infection does not occur (so that, ψ e = ψ c = ψ r = 0). Setting μ 2 = ψ e = ψ c = ψ r = 0 in the model (8) 
It is easy to show that the system has a unique EEP, of the form
, whenever R 01 > 1. We claim the following: Theorem 5. The unique endemic equilibrium, ε 2 , of the reduced model is LAS wheneverR 01 > 1. Proof . The proof is based on using the technique in (Hethcote and Thieme (1985) ) , which employs a Krasnoselskii sub-linearity trick. The approach essentially entails showing that the linearization of the system (17), around the equilibrium ε 2 , has solutions of the form Firstly, all the negative terms in the last three equations of the system(19) are moved to their respective left hand sides. Solving these equations of (19) and substituting the result into the remaining equations and simplifying, gives the equivalent system,
where, , ) ( (19), and using the fact that the matrix M is non-negative, gives
Then, it follows from the above inequality that * * 3
,which contradicts Re(F i (θ)) ≥ 0 . Hence, Re(θ) < 0, so that the endemic equilibrium, ε 2 , is LAS if R 01 > 1. The epidemiological implication of Theorem 5 is that the disease will persist in the community if the reproduction threshold (R 01 ) exceeds unity.
VII. Global Stability of EEP: Special Case
The global asymptotic stability of EEP, ε 2 , of the reduced model (17) is considered for the case when after taking vaccination some people get complete immunity (i.e. the unsuccessful vaccination rate (1 − σ) = 0). 
VIII. Numerical Simulations and Discussions
In this section, we have drawn some graphical presentations using data from Table 2 . Here we have collected some data from Bangabandhu Shekh Mujibur Rahman Medical University and we assumed some data for our convenience. In figure 1 , prevalence is slowly decreases with vaccination when R 0 =0.8595 and also decreases without vaccination when R 0 =0.8611. In figure 2 , prevalence is very high when R 0 = 1.1204 in absence of vaccination and prevalence is gradually increasing when R 0 = 1.1101 in presence of vaccination. In figure 3 , total infection decreases when R 0 = 0.8611 in absence of vaccination and also decreases and reduces to zero when R 0 = 0.8595 in presence of vaccination. In figure 4 , total infection is highly increases without vaccination when R 0 = 1.1204 and with vaccination, at the beginning disease increasing and smoothly increases when R 0 = 1.1101. From which it is evident that the vaccine has a positive impact, since it reduces the number of infection in comparison to the case when the vaccination is not used. 
IX. Result
We rigorously analyzed (mathematically and numerically) the dynamics of HBV in our model. Some mathematical and epidemiological findings of our study are given below: 1. The model has a disease free equilibrium (DFE) which is asymptotically stable if 1 0  R and unstable if 1 0  R . We found that, the model has a unique endemic equilibrium point and discuss the local stability at EEP using Sub-linearity trick when 1 0  R and globally asymptotically stable for a special case when 0 ) 1 (   
X. Conclusions
A deterministic model for the transmission dynamics of HBV in a population is designed and rigorously analyzed. Some of the main findings of the study include the following:
(i) The model exhibits a phenomenon of backward bifurcation, where a stable DFE co-exists with a suitable EEP when the associated reproduction number is less than unity. In the absence of re-infection the DFE is globally asymptotically stable whenever its associated reproduction number is less than unity. The model has an EEE which is globally asymptotically stable for a special case.
(ii) The model does not undergo backward bifurcation when re-infection terms are neglected.
